MedTrace Logo

Clinical Outcomes of an New EDOF IOL (Isopure®)

NCT05704686 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2023-01-30

No results posted yet for this study

Summary

Single-center, retrospective, open-label observational study aiming to evaluate visual outcomes and patient satisfaction after bilateral implantation of Isopure® EDOF-IOL with a mono-minovision target.

Conditions

  • Lens Opacities
  • Cataract
  • Pseudophakia

Interventions

DEVICE

Isopure 1.2.3 intraocular EDOF lens implantation

Bilateral Isopure 1.2.3 intraocular EDOF IOL implantation during a routine cataract surgery.

Sponsors & Collaborators

  • Kristof Vandekerckhove, MD, MBA

    lead OTHER

Principal Investigators

  • Kristof Vandekerckhove, MD · Vista Alpina Eye Clinic

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-26
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05704686 on ClinicalTrials.gov